Rosacea you notice in photos first.
A persistent pink that settles across the cheeks and nose and never fully leaves. It is not the same as a sensitive flush or a bad sunscreen day. Rosacea is a chronic inflammatory skin condition with neurovascular dysregulation — and in the Arizona climate (intense UV, dry heat, sudden temperature shifts) it tends to run more active than it would elsewhere.
At Desert Bloom Skincare in Scottsdale, Dr. Natalya Borakowski, NMD approaches rosacea straightforwardly: identify the subtype, separate what an aesthetic clinic does well from what a dermatologist owns, and sequence the work so the skin calms before it gets pushed. Rosacea is managed, not cured — the plan she builds is a long-term one.
Rosacea has four recognized subtypes: erythematotelangiectatic (persistent central-face redness with visible vessels — the most common pattern), papulopustular (redness with inflammatory bumps and pustules), phymatous (skin thickening, typically on the nose), and ocular (gritty, burning eyes; recurrent styes). Most patients have one dominant pattern with features from one or two others — and the subtype determines who leads the plan.
The two components of rosacea
Vascular component
Redness and visible vessels — laser-treatable
The vascular component shows up as persistent central-face erythema, diffuse background pink, and named telangiectasias (the fine red lines across cheeks and nose). This is the part long-pulsed Nd:YAG 1064 nm laser is designed for — the wavelength reaches the dilated vessel without significant melanin interference, which makes it the appropriate vascular target across Fitzpatrick I–VI. KTP 532 nm is the alternative for isolated superficial red vessels in lighter skin types.
Inflammatory component
Papules, pustules — topical and oral, not laser
The inflammatory component shows up as papules, pustules, and intermittent flare-ups that look closer to acne than to flushing. This is the dermatology lane — prescription topicals (metronidazole, ivermectin, azelaic acid, brimonidine, oxymetazoline) and low-dose oral doxycycline calm the inflammation. Laser work is deferred during active papulopustular flares: energy-based treatments work better on a calmer baseline and can aggravate active inflammation.
Aesthetic lane at Desert Bloom
Treatments we offer for rosacea
Nd:YAG 1064 nm · Vascular
Vein & Redness Removal
Long-pulsed Nd:YAG 1064 nm directed at individual visible vessels and focal patches of telangiectasia, plus diffuse background erythema. The primary vascular tool for rosacea; safe across Fitzpatrick I–VI.
Alexandrite 755 nm · Adjacent damage
Photo Facial
Targeted at the sun-damage pattern that often accompanies long-standing rosacea — uneven pigment, brown spots, photoaging. Photo Facial does not treat the rosacea vascular component itself; it addresses the adjacent sun damage in Fitzpatrick I–III patients only.
Hydration · Adjunct
HydroGlass Facial
A gentle, no-downtime hydration protocol (HydroPeptide) built for reactive, dehydrated rosacea-prone skin. Used between laser sessions for barrier support — no peel acids, no abrasive exfoliation, no heat-driven steps.
Calming · Adjunct
Organic Signature Facial
A bespoke, plant-based calming facial customized for sensitive and rosacea-prone skin. Used during quieter periods to maintain a calm baseline between laser series. No retinoids, no glycolic-acid layering, no steam.
Find your route
Which lane should lead — aesthetic or medical?
Final routing happens at consultation after an in-person assessment. The cards below describe the typical starting path based on which component dominates.
Persistent central-face redness with visible vessels — no active bumps.
→See vein and redness removal — Erythematotelangiectatic pattern. Vascular lane leads: long-pulsed Nd:YAG 1064 nm, KTP 532 nm for isolated superficial red vessels in lighter skin types.
Redness with papules, pustules, or pus-filled bumps along with the flush.
→Coordinate with dermatology — Papulopustular pattern. Dermatology leads first — prescription topicals (metronidazole, ivermectin, azelaic acid) or low-dose oral doxycycline. Laser is deferred until the inflammatory component is controlled.
Skin thickening or nodular changes on the nose or central face.
→Refer to dermatology — Phymatous pattern. Dermatology or oculoplastics owns this lane — not aesthetic laser.
Gritty, burning eyes; recurrent styes alongside facial redness.
→Refer to ophthalmology — Ocular rosacea. Needs ophthalmology or dermatology evaluation. Aesthetic laser does not address the eye component.
Rosacea — frequently asked
What is the difference between rosacea and general facial redness?
Facial flushing is a symptom — anyone can develop it from sun, wind, or a single spicy meal. Rosacea is a chronic condition with neurovascular dysregulation: the redness persists between triggers, the vessels stay dilated, and the skin remains reactive. If the color comes and goes fully, it may not be rosacea. If it never fully settles, that points toward a rosacea diagnosis.
Can rosacea be cured?
No. Rosacea is managed, not cured. Long-pulsed Nd:YAG 1064 nm laser can meaningfully reduce visible vessels and diffuse background redness, sometimes for years — but the underlying condition and its tendency to flare remain. Maintenance sessions and trigger avoidance are part of the long-term picture.
What is the best laser for rosacea?
Long-pulsed Nd:YAG 1064 nm. The wavelength reaches the dilated vessel without significant melanin interference, which is why it is appropriate across Fitzpatrick I–VI. KTP 532 nm is reserved for isolated superficial red vessels in lighter skin types. Alexandrite 755 nm is not used for the rosacea vascular component and is contraindicated for vascular work in Fitzpatrick IV–VI. Generic IPL is not the route Dr. Borakowski uses for true rosacea.
Is laser safe for rosacea if I have darker skin?
Yes, with the right wavelength. Long-pulsed Nd:YAG 1064 nm is safe across Fitzpatrick I–VI. Alexandrite 755 nm and KTP 532 nm carry a higher risk of pigmentary change in darker skin and are not used for rosacea vascular work in Fitzpatrick IV–VI. Rosacea in darker skin often presents as warm, dusky central-face color rather than bright pink — we do a test spot before committing to a series.
What triggers rosacea flare-ups?
The most common triggers are UV and sun exposure, heat (hot drinks, hot showers, sauna), alcohol (red wine especially), spicy foods, wind, sudden temperature shifts, stress, and strenuous cardio. Individual patterns vary. Keeping a short trigger log for a few weeks is more useful than a generic avoid-list.
Should I see a dermatologist or an aesthetic clinic?
If your rosacea is predominantly inflammatory — many papules, pustules, ocular involvement — start with a dermatologist. Prescription topicals and antibiotic therapy live there. If your rosacea is predominantly vascular — diffuse persistent redness, named vessels, flushing tied to heat or sun — an aesthetic clinic with long-pulsed Nd:YAG 1064 nm laser is the more direct path. Many people coordinate between both.
How many sessions will I need?
A typical course for diffuse erythema is 3–5 Nd:YAG sessions spaced 4–6 weeks apart, with maintenance every 6–12 months. Targeted Vein and Redness Removal for focal vessels usually needs 2–4 sessions. Severe or extensive distribution may need more. Dr. Borakowski estimates the full plan at consultation, not per-session.
Why do I need to avoid retinoids and physical exfoliation?
Rosacea-prone skin has a compromised barrier. Retinoids, glycolic and salicylic acids, scrubs, brushes, and microdermabrasion all strip that barrier further and can provoke flare-ups. Retinoids may be tolerated at low frequency during quiet periods, but they must be paused at the first sign of an active flare. The work holds longer when the baseline is calm.
Treatment plan led by
Founder, Desert Bloom Skincare · 17 Years Experience
References
- 1.
Gallo RL, Granstein RD, Kang S, et al.. Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol; 2018.
DOI: 10.1016/j.jaad.2017.08.037
PMID: 29089180
- 2.
Thiboutot D, Anderson R, Cook-Bolden F, et al.. Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol; 2020.
DOI: 10.1016/j.jaad.2020.01.077
PMID: 32035944
- 3.
Zhai Q, Wang Y, Liu Y, et al.. Meta-Analysis of the Efficacy of Intense Pulsed Light and Pulsed-Dye Laser Therapy in the Management of Rosacea. J Cosmet Dermatol; 2024.
DOI: 10.1111/jocd.16549
PMID: 39240125
- 4.
Ozyurt K, Colgecen E, Baykan H, Ozturk P, Ozkose M. Treatment of superficial cutaneous vascular lesions: experience with the long-pulsed 1064 nm Nd:YAG laser. ScientificWorldJournal; 2012.
DOI: 10.1100/2012/197139
PMID: 23028248
